| 0 |
APPLICATION SITE ABSCESS |
1 |
0.0172 |
| 1 |
BLOOD LACTIC ACID |
1 |
0.0078 |
| 2 |
COLD TYPE HAEMOLYTIC ANAEMIA |
1 |
0.0043 |
| 3 |
TRI-IODOTHYRONINE INCREASED |
1 |
0.0025 |
| 4 |
MULTIPLE DRUG THERAPY |
1 |
0.0013 |
| 5 |
HEPATIC HAEMORRHAGE |
1 |
0.0012 |
| 6 |
CORONARY ARTERY DISSECTION |
1 |
0.0012 |
| 7 |
ANTINUCLEAR ANTIBODY INCREASED |
1 |
0.0010 |
| 8 |
ALLERGY TO ANIMAL |
1 |
0.0009 |
| 9 |
B-LYMPHOCYTE COUNT DECREASED |
1 |
0.0007 |
| 10 |
EMOTIONAL POVERTY |
1 |
0.0006 |
| 11 |
HYPOGEUSIA |
1 |
0.0005 |
| 12 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
3 |
0.0005 |
| 13 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 14 |
PATELLA FRACTURE |
1 |
0.0004 |
| 15 |
SEDATION COMPLICATION |
1 |
0.0004 |
| 16 |
LIP BLISTER |
1 |
0.0004 |
| 17 |
CLUMSINESS |
1 |
0.0004 |
| 18 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 19 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 20 |
TENSION HEADACHE |
1 |
0.0002 |
| 21 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 22 |
PHLEBITIS |
1 |
0.0002 |
| 23 |
BRADYPHRENIA |
1 |
0.0002 |
| 24 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 25 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 26 |
SENSORY LOSS |
1 |
0.0001 |
| 27 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 28 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 29 |
LACERATION |
1 |
0.0001 |
| 30 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 31 |
HEPATIC FAILURE |
3 |
0.0001 |
| 32 |
FOOT DEFORMITY |
1 |
0.0001 |
| 33 |
SNEEZING |
2 |
0.0001 |
| 34 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 35 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 36 |
ANOSMIA |
1 |
0.0001 |
| 37 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 38 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 39 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 40 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 41 |
PELVIC PAIN |
1 |
0.0001 |
| 42 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 43 |
ORAL HERPES |
1 |
0.0001 |
| 44 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 45 |
LOCALISED INFECTION |
1 |
0.0000 |
| 46 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 47 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 48 |
SEDATION |
1 |
0.0000 |
| 49 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 50 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 51 |
FEELING COLD |
1 |
0.0000 |
| 52 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 53 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 54 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 55 |
GAIT INABILITY |
1 |
0.0000 |
| 56 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 57 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 58 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 59 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 60 |
BALANCE DISORDER |
2 |
0.0000 |
| 61 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 62 |
THROAT IRRITATION |
1 |
0.0000 |
| 63 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 64 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 65 |
SWELLING |
2 |
0.0000 |
| 66 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 67 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 68 |
LUNG DISORDER |
1 |
0.0000 |
| 69 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 70 |
DEPRESSED MOOD |
1 |
0.0000 |
| 71 |
RASH PRURITIC |
1 |
0.0000 |
| 72 |
NECK PAIN |
1 |
0.0000 |
| 73 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 74 |
SWELLING FACE |
1 |
0.0000 |
| 75 |
MOBILITY DECREASED |
1 |
0.0000 |
| 76 |
HOT FLUSH |
1 |
0.0000 |
| 77 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 78 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 79 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 80 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 81 |
COVID-19 |
2 |
0.0000 |
| 82 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 83 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 84 |
MIGRAINE |
1 |
0.0000 |
| 85 |
HEART RATE INCREASED |
1 |
0.0000 |
| 86 |
SINUSITIS |
1 |
0.0000 |
| 87 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 88 |
OVERDOSE |
2 |
0.0000 |
| 89 |
FALL |
3 |
0.0000 |
| 90 |
DECREASED APPETITE |
2 |
0.0000 |
| 91 |
BACK PAIN |
2 |
0.0000 |
| 92 |
PALPITATIONS |
1 |
0.0000 |
| 93 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 94 |
INFECTION |
1 |
0.0000 |
| 95 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 96 |
HYPOAESTHESIA |
1 |
0.0000 |
| 97 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 98 |
PARAESTHESIA |
1 |
0.0000 |
| 99 |
TREMOR |
1 |
0.0000 |
| 100 |
DIZZINESS |
3 |
0.0000 |
| 101 |
URTICARIA |
1 |
0.0000 |
| 102 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 103 |
MUSCLE SPASMS |
1 |
0.0000 |
| 104 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 105 |
DYSPNOEA |
3 |
0.0000 |
| 106 |
FATIGUE |
4 |
0.0000 |
| 107 |
ALOPECIA |
1 |
0.0000 |
| 108 |
HYPOTENSION |
1 |
0.0000 |
| 109 |
SOMNOLENCE |
1 |
0.0000 |
| 110 |
ARTHRALGIA |
2 |
0.0000 |
| 111 |
CONSTIPATION |
1 |
0.0000 |
| 112 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 113 |
FEELING ABNORMAL |
1 |
0.0000 |
| 114 |
WEIGHT DECREASED |
1 |
0.0000 |
| 115 |
ANXIETY |
1 |
0.0000 |
| 116 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 117 |
ASTHENIA |
1 |
0.0000 |
| 118 |
PRURITUS |
1 |
0.0000 |
| 119 |
NAUSEA |
2 |
0.0000 |
| 120 |
RASH |
1 |
0.0000 |
| 121 |
VOMITING |
1 |
0.0000 |
| 122 |
PAIN |
1 |
0.0000 |
| 123 |
HEADACHE |
1 |
0.0000 |
| 124 |
DIARRHOEA |
1 |
0.0000 |
| 125 |
OFF LABEL USE |
1 |
0.0000 |
| 126 |
DRUG INEFFECTIVE |
1 |
0.0000 |